Calithera Biosciences, Inc
CALA
CALA was delisted on the 1st of February, 2023.
81 hedge funds and large institutions have $105M invested in Calithera Biosciences, Inc in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 24 increasing their positions, 27 reducing their positions, and 18 closing their positions.
78% more call options, than puts
Call options by funds: $494K | Put options by funds: $277K
5% more capital invested
Capital invested by funds: $100M → $105M (+$4.82M)
10% less funds holding
Funds holding: 90 → 81 (-9)
11% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 27
50% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$12.1M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
+$931K |
| 3 |
JP Morgan Chase
New York
|
+$492K |
| 4 |
Two Sigma Investments
New York
|
+$350K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$314K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$4.17M |
| 2 |
American Century Companies
Kansas City,
Missouri
|
-$2.77M |
| 3 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$1.49M |
| 4 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$1.01M |
| 5 |
AC
Ascend Capital
Orinda,
California
|
-$960K |
CALA Hedge Fund Activity: Q3 2018 in Review
81 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Calithera Biosciences, Inc (CALA) for Q3 2018, worth a combined $105M — up 4.8% from $100M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of CALA and 9 opened new positions — a net loss of 9 holders — while 27 trimmed existing stakes and 24 added.
The largest buyer was BVF Inc, opening a new position worth an estimated $12.1M. The largest seller was Wellington Management Group, cutting an estimated $4.17M.
- 81 institutional investors held Calithera Biosciences, Inc (CALA) as of Q3 2018, down from 90 in Q2 2018.
- Funds reported $105M of Calithera Biosciences, Inc stock for Q3 2018, up 4.8% quarter-over-quarter.
- 9 funds opened new Calithera Biosciences, Inc positions in Q3 2018 and 18 closed out, a net change of -9 holders.
- The largest Calithera Biosciences, Inc buyer in Q3 2018 was BVF Inc, an estimated $12.1M added.
- The largest Calithera Biosciences, Inc seller in Q3 2018 was Wellington Management Group, an estimated $4.17M sold.
Based on aggregated 13F filings for Q3 2018.